# FDA recall D-1552-2020

> **SCA Pharmaceuticals** · Class I · drug recall initiated 2020-07-29.

## Product

Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-46, Bar Code 70004065046.

## Reason for recall

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

## Distribution

Nationwide within the U.S.

## Key facts

- **Recall number:** D-1552-2020
- **Recalling firm:** SCA Pharmaceuticals
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-07-29
- **Report date:** 2020-09-02
- **Termination date:** 2021-05-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Windsor, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1552-2020

## Citation

> AI Analytics. FDA recall D-1552-2020. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1552-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*